You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

RITODRINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ritodrine Hydrochloride patents expire, and what generic alternatives are available?

Ritodrine Hydrochloride is a drug marketed by Abraxis Pharm and Hospira and is included in five NDAs.

The generic ingredient in RITODRINE HYDROCHLORIDE is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.

Drug patent expirations by year for RITODRINE HYDROCHLORIDE
Recent Clinical Trials for RITODRINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 3
Assiut UniversityPhase 4
Assiut UniversityN/A

See all RITODRINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for RITODRINE HYDROCHLORIDE

US Patents and Regulatory Information for RITODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071188-001 Jul 23, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071619-001 Feb 28, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abraxis Pharm RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071189-001 Jul 23, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071618-001 Feb 28, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.